"LM_ID"	"COMMON_NAME"	"SYSTEMATIC_NAME"	"FORMULA"	"MASS"	"CATEGORY"	"MAIN_CLASS"	"SUB_CLASS"	"CLASS_LEVEL4"	"SYNONYMS"	"INCHI_KEY"	"INCHI"	"SMILES"	"KEGG_ID"	"HMDBID"	"CHEBI_ID"	"ABBREVIATION"	"PUBCHEM_COMPOUND_ID"	"LIPIDBANK_ID"	"SWISSLIPIDS_ID"	"CAYMAN_ID"	"ALT_CATEGORIES"	"ALT_MAIN_CLASSES"	"ALT_SUB_CLASSES"	"ALT_CLASS_LEVEL4S"	"TAXONOMY"	"CITATION"
"LMSP0505AE04"	"type II B antigen(d18:1/22:0)"	"Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)"	"C78H142N2O32"	"1618.95458"	"Sphingolipids [SP]"	"Neutral glycosphingolipids [SP05]"	"Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]"	"-"	"-"	"HAUZOAFRCMFDAG-AWOQRUSTSA-N"	"InChI=1S/C78H142N2O32/c1-5-7-9-11-13-15-17-19-20-21-22-23-24-26-28-30-32-34-36-38-54(88)80-47(48(87)37-35-33-31-29-27-25-18-16-14-12-10-8-6-2)44-101-74-66(99)63(96)69(53(43-85)107-74)108-77-67(100)70(58(91)50(40-82)104-77)110-73-55(79-46(4)86)60(93)68(52(42-84)106-73)109-78-72(112-75-64(97)61(94)56(89)45(3)102-75)71(59(92)51(41-83)105-78)111-76-65(98)62(95)57(90)49(39-81)103-76/h35,37,45,47-53,55-78,81-85,87,89-100H,5-34,36,38-44H2,1-4H3,(H,79,86)(H,80,88)/b37-35+/t45-,47+,48-,49-,50-,51-,52-,53-,55-,56-,57+,58+,59+,60-,61-,62+,63-,64+,65-,66-,67-,68-,69-,70+,71+,72-,73+,74-,75-,76-,77+,78+/m1/s1"	"[C@](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O[C@H]5O[C@H](CO)[C@H](O)[C@H](O)[C@H]5O)[C@H]4O[C@H]4O[C@H](C)[C@@H](O)[C@@H](O)[C@@H]4O)[C@H](O)[C@H]3NC(=O)C)[C@H]2O)[C@H](O)[C@H]1O)([H])(NC(CCCCCCCCCCCCCCCCCCCCC)=O)[C@]([H])(O)/C=C/CCCCCCCCCCCCC"	"-"	"-"	"-"	"Hex(4)-HexNAc-Fuc-Cer 40:1;O2"	"178331934"	"-"	"-"	"-"	"-"	"-"	"-"	"-"	"-"	"-"